OsI_030282 Antibody

Shipped with Ice Packs
In Stock

Description

Current Status of "OsI_030282 Antibody" in Scientific Literature

The term "OsI_030282 Antibody" does not appear in any of the indexed scientific publications, regulatory filings, or antibody databases reviewed, including:

  • Drugs.com (monoclonal antibody listings)

  • Antibody Society’s therapeutic antibody database

  • Clinical trial registries (e.g., ClinicalTrials.gov)

  • Kyowa Kirin or Bio-Techne antibody catalogs

No matches were identified for this designation in the context of structure, target antigen, clinical applications, or research data.

Nomenclature Discrepancies

Antibodies are often designated using standardized naming conventions (e.g., INN/WHO guidelines). The format "OsI_030282" does not align with established nomenclature systems for monoclonal antibodies, which typically include:

  • Prefix: Indicates source or target (e.g., rituximab targets CD20).

  • Infixed target: For bispecific antibodies (e.g., amivantamab targets EGFR and c-MET).

  • Suffix "-mab": Denotes monoclonal antibody .

Experimental or Proprietary Designation

"OsI_030282" may represent:

  • An internal research identifier from a private entity.

  • A discontinued or preclinical candidate not yet published.

  • A misspelled or mistranscribed name (e.g., confusion with catalog numbers like NBP2-52682APC or H00006428-M08 ).

Recommendations for Further Investigation

To resolve ambiguities and identify relevant data, consider the following steps:

ActionPurpose
Cross-reference with antibody databases (e.g., The Antibody Society, UniProt)Confirm naming conventions and structural data.
Contact manufacturers (e.g., Bio-Techne, Creative Biolabs)Clarify catalog numbers or proprietary identifiers.
Review patent filings (e.g., USPTO, WIPO)Identify undisclosed developmental candidates.

Related Antibodies with Similar Naming Patterns

While "OsI_030282" remains unidentified, the following antibodies from the search results highlight naming conventions and therapeutic applications:

CD20-Targeting Antibodies

AntibodyBrand Name(s)Key Applications
RituximabRituxan, TruximaNon-Hodgkin’s lymphoma, rheumatoid arthritis
OfatumumabKesimptaMultiple sclerosis, chronic lymphocytic leukemia

SARS-CoV-2 Antibodies

AntibodyBrand NameTarget
RegdanvimabRegkironaSARS-CoV-2 spike protein

Mechanisms of Antibody Diversity

Though unrelated to "OsI_030282," the search results emphasize how antibody diversity is generated:

  • V(D)J recombination: Random assembly of gene segments (V, D, J) in B cells .

  • Somatic hypermutation: Post-antigen exposure mutations enhancing affinity .

  • Class switching: Transition from IgM/IgD to IgG/IgA/IgE .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
OsI_030282 antibody; Uncharacterized protein OsI_030282 antibody; Unknown protein AN08 from 2D-PAGE of anther antibody
Target Names
OsI_030282
Uniprot No.

Q&A

What is OsI_030282 and what are the key specifications of antibodies targeting this protein?

OsI_030282 is an uncharacterized protein from Oryza sativa subsp. indica (Rice) with the UniProt accession number A2Z139. The commercially available antibody (product code CSB-PA386120XA01OFF) is a rabbit-raised polyclonal antibody generated using recombinant OsI_030282 protein as the immunogen. This antibody is supplied in liquid form containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative. It has been purified using antigen affinity chromatography and validated for ELISA and Western Blot applications .

Key specifications include:

  • Isotype: IgG

  • Clonality: Polyclonal

  • Host species: Rabbit

  • Target species reactivity: Oryza sativa subsp. indica (Rice)

  • Applications: ELISA, Western Blot (WB)

  • Storage conditions: -20°C or -80°C

How should OsI_030282 Antibody be stored and handled to maintain optimal activity?

For maximum stability and activity retention, the OsI_030282 Antibody should be stored at -20°C or -80°C immediately upon receipt. Repeated freeze-thaw cycles should be strictly avoided as they can compromise antibody functionality and specificity. For laboratory use, it is recommended to aliquot the antibody into smaller volumes based on experimental needs to minimize freeze-thaw events .

Handling recommendations:

  • Thaw antibody aliquots on ice or at 4°C

  • Prepare working dilutions fresh before each experiment

  • Return unused antibody to -20°C promptly

  • For short-term storage (1-2 weeks), antibody can be kept at 4°C

  • Avoid exposure to light when using fluorescently-labeled secondary antibodies

What is the recommended protocol for using OsI_030282 Antibody in Western blot applications?

When using OsI_030282 Antibody for Western blot applications, researchers should follow this methodological approach for optimal results:

Sample preparation:

  • Extract proteins from rice tissues using appropriate lysis buffer (e.g., RIPA buffer with protease inhibitors)

  • Quantify protein concentration using Bradford or BCA assay

  • Denature samples with Laemmli buffer (containing SDS and β-mercaptoethanol) at 95°C for 5 minutes

  • Load 25-50 μg protein per lane on SDS-PAGE gel

Western blot procedure:

  • Separate proteins by SDS-PAGE (10-12% acrylamide gel recommended)

  • Transfer to PVDF or nitrocellulose membrane (wet transfer at 100V for 1 hour or 30V overnight)

  • Block membrane with 5% non-fat milk or BSA in TBST for 1 hour at room temperature

  • Incubate with primary antibody (OsI_030282 Antibody) at 1:500-1:1000 dilution overnight at 4°C

  • Wash 3-5 times with TBST, 5 minutes each

  • Incubate with HRP-conjugated secondary antibody at 1:5000-1:10000 for 1 hour at room temperature

  • Wash 3-5 times with TBST, 5 minutes each

  • Develop using ECL substrate and detect signal using X-ray film or digital imaging system

For enhanced detection specificity, include positive control (rice extract known to express OsI_030282) and negative control (non-rice plant extract) .

How can researchers verify the specificity of OsI_030282 Antibody for their experimental systems?

Verification of antibody specificity is crucial for experimental validity. For OsI_030282 Antibody, implement these multi-faceted verification strategies:

Peptide competition assay:

  • Pre-incubate the antibody with 5-10× excess of recombinant OsI_030282 protein (immunogen) for 2 hours at room temperature

  • In parallel, prepare normal antibody dilution without competing peptide

  • Perform Western blot with both preparations

  • Specific signal should be significantly reduced or eliminated in the peptide-blocked sample

Genetic validation:

  • If available, use RNAi knockdown or CRISPR knockout lines for OsI_030282

  • Compare antibody reactivity between wild-type and modified samples

  • Signal should be proportionally reduced in knockdown lines or absent in knockout lines

Cross-species reactivity assessment:

  • Test antibody against protein extracts from related plant species with known sequence homology to OsI_030282

  • Signal intensity should correlate with sequence conservation

  • Unexpected cross-reactivity may indicate non-specific binding

Molecular weight verification:

  • Compare observed band size with predicted molecular weight of OsI_030282

  • Account for potential post-translational modifications that may alter migration patterns

  • Multiple bands may indicate isoforms, degradation products, or non-specific binding

What considerations are important for optimizing immunoprecipitation using OsI_030282 Antibody?

Successful immunoprecipitation (IP) with OsI_030282 Antibody requires careful optimization of multiple parameters:

Lysis buffer selection:

  • For protein-protein interaction studies: Use non-denaturing buffers (e.g., 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate)

  • For PTM analysis: Consider denaturing conditions (1% SDS with subsequent dilution before IP)

  • Always include protease inhibitors and phosphatase inhibitors (if studying phosphorylation)

Antibody coupling approaches:

  • Direct coupling: Pre-immobilize antibody to protein A/G beads using crosslinkers (e.g., BS3, DSS)

  • Indirect coupling: Add antibody to lysate followed by protein A/G beads

  • For high background: Consider pre-clearing lysate with protein A/G beads before adding antibody

Optimization parameters:

  • Antibody amount: Test 2-10 μg per mg of protein lysate

  • Incubation time: 2 hours at room temperature vs. overnight at 4°C

  • Wash stringency: Adjust salt concentration (150-500 mM NaCl) and detergent (0.1-1% NP-40)

Table 1: Troubleshooting guide for immunoprecipitation with OsI_030282 Antibody

IssuePotential CausesRecommended Solutions
No target protein recoveryInsufficient antibody, epitope masking, harsh lysis conditionsIncrease antibody amount, try different lysis buffers, verify protein expression
High backgroundInsufficient washing, non-specific bindingIncrease wash stringency, add BSA to washing buffer, pre-clear lysate
Co-IP failureBuffer incompatibility, weak interactionsTest milder detergents, shorter washing times, crosslinking before lysis
Contaminating bandsAntibody heavy/light chainsUse HRP-conjugated secondary antibodies specific to light chain, employ antibody crosslinking

How can OsI_030282 Antibody be utilized for mass spectrometry-based characterization of protein complexes?

Mass spectrometry-based characterization of OsI_030282-containing complexes provides deeper insights into protein function. Follow this methodological approach:

Sample preparation workflow:

  • Perform immunoprecipitation as described above, scaling up 5-10× for adequate protein recovery

  • Elute proteins under mild conditions to maintain complex integrity (e.g., peptide competition or low pH glycine buffer)

  • Concentrate sample using TCA precipitation or centrifugal filters

  • Resolve complex components by SDS-PAGE and visualize with colloidal Coomassie or silver staining

Mass spectrometry preparation:

  • Excise bands of interest or process entire lanes using in-gel digestion with trypsin

  • Extract peptides and desalt using C18 spin columns

  • Analyze by LC-MS/MS using appropriate acquisition methods (e.g., data-dependent acquisition)

Data analysis strategy:

  • Search raw data against appropriate rice protein database

  • Filter results using strict criteria (FDR <1%)

  • Use appropriate controls (IP with non-specific IgG) to exclude non-specific binders

  • Implement quantitative approaches (spectral counting, MS1 intensity, or labeled methods) to assess enrichment

Verification of interactions:

  • Confirm key interactions by reciprocal IP using antibodies against identified partners

  • Validate biological relevance through functional assays

  • Consider orthogonal methods (e.g., proximity ligation assay, BiFC) for in vivo validation

What approaches can researchers use to study post-translational modifications of OsI_030282?

Investigation of post-translational modifications (PTMs) requires specialized strategies:

Phosphorylation analysis:

  • Immunoprecipitate OsI_030282 from plants treated with or without relevant stimuli

  • Resolve by SDS-PAGE and detect phosphorylation by:

    • Western blot using phospho-specific stains (Pro-Q Diamond)

    • Western blot with phospho-amino acid specific antibodies (p-Ser, p-Thr, p-Tyr)

  • For site identification, digest IP products and enrich phosphopeptides using:

    • Immobilized metal affinity chromatography (IMAC)

    • Titanium dioxide (TiO2) enrichment

  • Analyze enriched fractions by LC-MS/MS with neutral loss scanning or data-dependent acquisition

Ubiquitination detection:

  • Add deubiquitinase inhibitors to lysis buffer (e.g., N-ethylmaleimide, PR-619)

  • Perform IP under denaturing conditions to preserve ubiquitin modifications

  • Analyze by Western blot using anti-ubiquitin antibodies

  • For site identification, look for the characteristic GG remnant on lysine residues by MS

Glycosylation assessment:

  • Treat immunoprecipitated OsI_030282 with glycosidases (PNGase F for N-linked, O-glycosidase for O-linked)

  • Analyze mobility shifts by Western blot

  • For glycan profiling, use specialized MS approaches or lectin arrays

Table 2: Comparison of PTM detection methods for OsI_030282

PTM TypeDetection MethodAdvantagesLimitationsSensitivity
PhosphorylationPhospho-stains, MSSite-specific information, quantifiableRequires enrichment, transient natureMedium-High
UbiquitinationAnti-Ub WB, MSCan distinguish poly-Ub chains, site identificationHighly dynamic, prone to degradationMedium
GlycosylationGlycosidase shifts, lectin blotsDistinguishes N- vs O-linked, glycan compositionComplex structures, heterogeneityLow-Medium
AcetylationAnti-acetyl WB, MSSite-specific, functional significanceOften substoichiometricMedium

How can chromatin immunoprecipitation (ChIP) be adapted to investigate potential DNA-binding properties of OsI_030282?

If investigating potential DNA interactions of OsI_030282, consider this optimized ChIP protocol:

Chromatin preparation:

  • Crosslink rice tissues with 1% formaldehyde for 10 minutes under vacuum

  • Quench with 0.125 M glycine for 5 minutes

  • Isolate nuclei using appropriate extraction buffer

  • Shear chromatin to 200-500 bp fragments using sonication (optimize cycles for rice tissues)

  • Verify fragmentation efficiency by agarose gel electrophoresis of decrosslinked aliquot

Immunoprecipitation:

  • Pre-clear chromatin with protein A/G beads and non-specific IgG

  • Divide chromatin into experimental (OsI_030282 Antibody) and control (IgG) samples

  • Incubate with antibodies overnight at 4°C with rotation

  • Add protein A/G beads and incubate for 2-3 hours

  • Perform sequential washes with increasing stringency:

    • Low salt buffer (150 mM NaCl)

    • High salt buffer (500 mM NaCl)

    • LiCl buffer

    • TE buffer

DNA recovery and analysis:

  • Elute protein-DNA complexes and reverse crosslinks (65°C overnight)

  • Digest proteins with proteinase K

  • Purify DNA using phenol-chloroform extraction or commercial kits

  • Quantify enrichment by qPCR for candidate regions

  • For genome-wide profiling, prepare libraries for ChIP-seq

Bioinformatic analysis:

  • Align sequencing reads to rice genome

  • Identify enriched regions (peaks) using appropriate algorithms

  • Perform motif discovery to identify potential binding sequences

  • Correlate binding sites with gene expression data

  • Validate findings with reporter gene assays

What strategies can resolve inconsistent or contradictory OsI_030282 detection patterns in different rice varieties?

When facing variable OsI_030282 detection across rice varieties, implement these systematic approaches:

Technical validation:

  • Sequence the OsI_030282 gene from each variety to identify potential polymorphisms

  • Compare protein sequence variations in the antibody epitope region

  • Standardize protein extraction protocols across all samples:

    • Use identical buffer compositions

    • Process tissues at the same developmental stage

    • Maintain consistent sample-to-buffer ratios

  • Include multiple housekeeping controls (e.g., actin, tubulin, GAPDH)

  • Perform reciprocal experiments with different antibody lots if available

Complementary methodologies:

  • Correlate protein detection (Western blot) with transcript levels (RT-qPCR)

  • Develop variety-specific qPCR primers spanning polymorphic regions

  • Consider raising new antibodies against conserved epitopes if necessary

  • Use mass spectrometry for orthogonal verification:

    • Target peptides from conserved regions

    • Apply multiple reaction monitoring (MRM) for quantification

Biological interpretation framework:

  • Document comprehensive metadata:

    • Precise growth conditions (temperature, light, humidity)

    • Developmental stage using standardized scales

    • Tissue-specific sampling procedures

  • Consider protein turnover dynamics:

    • Perform cycloheximide chase assays to measure stability

    • Compare protein half-life across varieties

  • Investigate post-transcriptional regulation:

    • miRNA targeting differences

    • RNA secondary structure variations

Statistical approach:

  • Implement factorial experimental design

  • Perform multi-way ANOVA to assess variety × condition interactions

  • Use mixed-effects models to account for batch variation

  • Apply appropriate multiple testing corrections

How should researchers design experiments to investigate the function of OsI_030282 in stress response pathways?

To investigate OsI_030282 function in stress responses, implement this multi-layered experimental design:

Expression profiling under stress conditions:

  • Subject rice plants to relevant stresses:

    • Abiotic: drought, salinity, temperature extremes, nutrient deficiency

    • Biotic: pathogen infection, herbivory

  • Collect tissues at multiple timepoints (early: 0, 1, 3, 6 hours; late: 12, 24, 48, 72 hours)

  • Analyze OsI_030282 expression by:

    • Western blot with OsI_030282 Antibody

    • RT-qPCR for transcript levels

    • Immunolocalization to assess subcellular redistribution

Functional genomics approaches:

  • Generate transgenic rice with modified OsI_030282 expression:

    • Overexpression lines (constitutive and stress-inducible promoters)

    • RNAi knockdown or CRISPR knockout lines

  • Phenotype plants under control and stress conditions:

    • Morphological parameters

    • Physiological responses

    • Yield components

  • Compare stress sensitivity/tolerance between transgenic and wild-type plants

Protein interaction dynamics:

  • Perform Co-IP with OsI_030282 Antibody under control and stress conditions

  • Identify differential interactors by mass spectrometry

  • Validate key interactions using BiFC or split luciferase assays

  • Map interaction domains through deletion constructs

PTM dynamics:

  • Analyze stress-induced PTM changes:

    • Phosphorylation state using Phos-tag gels

    • Ubiquitination patterns

    • Subcellular localization shifts

  • Identify responsible enzymes (kinases, E3 ligases)

  • Generate phosphomimic and phosphonull mutants to assess functional significance

Table 3: Multi-dimensional data collection for OsI_030282 stress response studies

Experimental LevelControl DataStress Treatment DataAnalytical MethodsExpected Insights
TranscriptBasal expressionTemporal induction patternsRT-qPCR, RNA-SeqTranscriptional regulation
ProteinAbundance, localizationChanges in levels, redistributionWestern blot, IFPost-transcriptional control
InteractomeConstitutive partnersStress-specific interactionsCo-IP, MS, BiFCFunctional complexes
PTMsBasal modification stateStress-induced changesMS, Phos-tag, WBRegulatory mechanisms
PhenotypeNormal developmentStress response alterationsPhysiology, yield componentsFunctional significance

What methodological considerations are important when comparing data from antibody-based detection of OsI_030282 with RNA-sequencing or proteomics studies?

Integrating multiple data types requires careful consideration of each method's strengths and limitations:

Data normalization approaches:

  • For Western blot quantification:

    • Use multiple housekeeping controls

    • Apply densitometry with linear range validation

    • Implement technical replicates (minimum of three)

  • For RNA-Seq data:

    • Consider appropriate normalization methods (TPM, FPKM, etc.)

    • Account for batch effects using ComBat or similar tools

    • Validate key findings with RT-qPCR

  • For proteomics data:

    • Evaluate different normalization strategies (global, spike-in, housekeeping)

    • Consider both spectral counting and intensity-based approaches

    • Assess technical and biological variance components

Correlation analysis framework:

  • Examine relationship between:

    • Transcript level (RNA-Seq) and protein abundance (Western blot/proteomics)

    • Antibody-based quantification and MS-based quantification

  • Calculate correlation coefficients using appropriate methods:

    • Pearson's r for linear relationships

    • Spearman's ρ for non-linear relationships

  • Visualize relationships with scatter plots and regression analysis

  • Investigate outliers as potential cases of post-transcriptional regulation

Addressing methodological biases:

  • Antibody limitations:

    • Epitope accessibility variations

    • Cross-reactivity with homologs

    • Limited dynamic range

  • RNA-Seq considerations:

    • RNA extraction efficiency differences

    • GC content bias

    • Read mapping ambiguity for close homologs

  • Proteomics challenges:

    • Protein extraction bias

    • Peptide ionization efficiency

    • Missing values in low-abundance proteins

Integration strategies:

  • Develop a consensus dataset using rank-based methods

  • Apply pathway analysis to identify shared functional enrichment

  • Use multi-omics integration tools (e.g., mixOmics, MOFA)

  • Consider time delays between transcription and translation when comparing dynamic responses

What are the emerging research directions for understanding OsI_030282 function in plant biology?

Future research on OsI_030282 is likely to expand in several promising directions based on current knowledge of uncharacterized plant proteins. These include comprehensive functional genomics approaches using CRISPR-Cas9 technology to generate precise mutations, advanced protein structure analysis through cryo-electron microscopy, and integrative systems biology approaches to place OsI_030282 within broader cellular networks. The continuing development of more specific antibodies and their application in cutting-edge single-cell analyses will likely yield new insights into tissue-specific functions and developmental regulation of this protein.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.